D-dimer for the diagnosis of venous thromboembolism in children.

To the Editor: Venous thromboembolism (VTE), including both deep venous thrombosis (DVT) and pulmonary embolism (PE), is an important cause of morbidity and mortality in children. Although there is heightened awareness of this disease and its risk factors in children, there has been minimal evaluation of diagnostic tests (clinical prediction models, imaging modalities, and D-dimer assays) in children compared to adults.(1) ELISA based D-dimer assays have excellent sensitivity for the diagnosis of VTE in adults and this may permit the exclusion of VTE.(2) However, the utility of D-dimer assays for VTE in children has not been evaluated. We performed a retrospective chart review of patients ≤21 years of age at Johns Hopkins Hospital with suspected VTE, imaging studies, and quantitative D-dimer. We used a discharge and billing database to identify patients and extracted information on potential risk factors, clinical findings, laboratory and imaging studies, and treatment. D-dimer was measured with an immunoturbidimetric assay on a Blood Coagulation System (BCS) analyzer (Advanced D-dimer; Dade-Behring) per the manufacturer's specifications. We identified 33 patients (20 male and 13 female) with diagnostic imaging studies and measurement of D-dimer within 72 hours. Twenty-six had acute VTE (15 DVT, 3 PE and 8 both], 6 with unchanged chronic VTE (5 DVT and 1 PE), and 1 without VTE (suspected PE). Most patients had multiple acquired risk factors for VTE with central venous catheters (54%), infections (40%), and immobility (42%) most frequent. D-dimer was significantly elevated in children with VTE (median 5.0, IQR 2.05-16.44) compared to children with negative evaluations for acute VTE (median 1.58, IQR 1.46-3.11, P 40 years old, 0.43-2.24 mg/L) and children (2-12 years old, 0.4-2.27 mg/L). Figure 1 D-dimer (log-scale) by diagnosis and the normal range for children 2 – 12 years of age We found that the D-dimer test was sensitive but only moderately specific for the diagnosis of VTE in children, and that the performance varied with the chosen cut-off. This assay is approved for the diagnosis of VTE in adults; the cut-off is 1.6 mg/L as the normal range is significantly higher than many D-dimer assays.(3) A D-dimer 1.75 mg/L was 92% sensitive (95% CI 75 – 99) and 57% specific (95% CI 18 – 90). Raising the threshold of the D-dimer to >2 mg/dl decreased the sensitivity to 77% (95% CI 56 – 91) while increasing the specificity to 71% (95% CI 29 – 96) for the diagnosis of VTE (Table 1). In a previous study of hospitalized adults from our institution,(4) the sensitivity of this test at a threshold of 2 mg/L was comparable (70% in adults versus 77% in children), however the specificity was considerably lower (42% in adults versus 71% in children). We calculated the area under the ROC [0.86 (95% CI 0.72-1.0)] to assess the performance of the D-dimer test to diagnose VTE. The greater the area under the curve, the better the performance of the diagnostic test with an area of 0.5 corresponding to a test that performs no better than flipping a coin. Table 1 Diagnostic Test Characteristics by Cut-Off (95% CI) While the utility of the D-dimer testing has been studied extensively in adults, its performance for the diagnosis of VTE in pediatric patients has not been evaluated. A report of children with PE from a single institution described elevated levels of D-dimer in 6 of 10, but the normal range was not described.(5) In children with acute thrombotic events, elevated D-dimer was found to be predictive of poor outcome (persistent thrombosis, VTE recurrence, or post-thrombotic syndrome); however, measurement of D-dimer was semi-quantitative and its predictive value for the diagnosis of VTE was not reported.(6) In both adults and children, an elevated D-dimer after treatment of VTE appears to be a risk factor for recurrent thrombus.(6-8) To our knowledge, this is the first report that describes the sensitivity of D-dimer measurements for the diagnosis of VTE in children. The incidence of VTE is significantly lower in children than adults, but perhaps even more challenging to diagnose. Compression ultrasonography of the lower extremities (sensitivity 91% and specificity 99%)(9) and MR venography (sensitivity 92% and specificity 95%)(10) have only been validated against the gold standard (contrast venography) in adults. D-dimer assays, in particular automated assays with rapid turn around times like the immunoturbidimetric assay used in this study, offer several advantages over other diagnostic modalities for VTE. They are relatively inexpensive and readily available in the outpatient and inpatient setting. A normal level in adults may potentially exclude VTE and avoid the need for expensive and time consuming imaging studies. Further prospective trials are necessary to validate our findings in children, as well as to address the utility of the D-dimer in selected subsets of pediatric patients.